小儿清热宣肺贴膏辅助治疗儿童哮喘急性发作的疗效及安全性  

Efficacy and Safety of Pediatric Qingre Xuanfei Plaster in Adjuvant Treatment of Pediatric Acute Asthma

作　　者：朱晓华[1] 李建[1] 杜云[1] 李明嫄 ZHU Xiao-hua;LI Jian;DU Yun;LI Ming-yuan(Department of Respiratory Medicine,Jiangxi Provincial Children’s Hospital,Nanchang 330006,China)

机构地区：[1]江西省儿童医院呼吸科,南昌330006

出　　处：《实用临床医学（江西）》2024年第6期51-54,共4页Practical Clinical Medicine

基　　金：江西省中医药管理局科技计划项目(2023A0076)。

摘　　要：目的探讨小儿清热宣肺贴膏辅助治疗儿童哮喘急性发作的临床疗效及安全性,为临床治疗提供参考。方法选取2024年1-7月在呼吸内科门诊治疗的6个月~6岁急性轻、中度哮喘发作儿童79例,采用随机数字法分为观察组40例和对照组39例。对照组采用常规治疗,观察组在对照组的基础上加用小儿清热宣肺贴膏穴位贴敷治疗。比较2组患儿连续用药5 d后的临床治疗效果和不良反应发生情况。结果观察组总有效率明显高于对照组(92.5%比74.4%,P<0.05)。观察组喘息、肺部哮鸣音消失时间较对照组缩短(P<0.05)。观察组局部皮疹1例,皮肤瘙痒1例,不良反应发生率为5.0%;对照组皮疹1例,不良反应发生率为2.5%,2组患儿不良反应发生率比较差异无统计学意义(P>0.05)。结论联合小儿清热宣肺贴膏穴位贴敷治疗儿童哮喘急性发作疗效好,且不良反应发生少,安全性高。Objective To explore the clinical efficacy and safety of Pediatric Qingre Xuanfei plaster in adjuvant treatment of acute asthma attacks in children so as to provide reference for clinical practice.Methods A total of 79 children aged from 6 months to 6 years with acute mild to moderate asthma attacks,who were admitted to the department of respiratory medicine from January to July 2024,were selected and divided into an observation group(40 cases)and a control group(39 cases)using the random number table method.The control group received conventional treatment,whereas the observation group was further given Pediatric Qingre Xuanfei plaster for acupoint application.The clinical efficacy and adverse reactions were compared between the 2 groups after 5 consecutive days of medication.Results The total effective rate in the observation group was significantly higher than that in the control group(92.5%vs 74.4%,P<0.05).The duration of wheezing and lung wheezing in the observation group was shorter than that in the control group(P<0.05).In the observation group,there was 1 case of local rash and 1 case of skin itching,with an incidence of adverse reactions of 5.0%;in the control group,there was 1 case of rash,with an incidence of adverse reactions of 2.5%;there was no statistically significant difference in the incidence of adverse reactions between the 2 groups(P>0.05).Conclusion The acupoint application with Pediatric Qingre Xuanfei plaster can be clinically effective in adjuvant treatment of acute asthma attacks in children,with few adverse reactions and relatively high safety.

关 键 词：小儿清热宣肺贴膏 儿童哮喘 急性发作 疗效 安全性 

分 类 号：R725.6[医药卫生—儿科]